GR3021014T3 - 2-Substituted quinolines, process for their preparation as well as their use in medicaments - Google Patents

2-Substituted quinolines, process for their preparation as well as their use in medicaments

Info

Publication number
GR3021014T3
GR3021014T3 GR960402365T GR960402365T GR3021014T3 GR 3021014 T3 GR3021014 T3 GR 3021014T3 GR 960402365 T GR960402365 T GR 960402365T GR 960402365 T GR960402365 T GR 960402365T GR 3021014 T3 GR3021014 T3 GR 3021014T3
Authority
GR
Greece
Prior art keywords
substituted
medicaments
substituted quinolines
preparation
well
Prior art date
Application number
GR960402365T
Other languages
Greek (el)
Inventor
Siegfried Dr Raddatz
Klaus-Helmut Dr Mohrs
Michael Dr Matzke
Romanis Fruchtmann
Armin Dr Hatzelmann
Christian Dr Kohlsdorfer
Reiner Pro Mueller-Peddinghaus
Pia Dr Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR3021014T3 publication Critical patent/GR3021014T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Earth Drilling (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

2-substituted quinolines of the general formula <IMAGE> The title compounds are prepared by reacting either the corresponding halomethylquinolines with substituted phenols, then optionally alkylating these and hydrolysing esters to acids, or by reacting phenyl-substituted quinolinecarboxylic acid derivatives with sulphonamides. The novel phenyl-substituted quinolines can be used as active compounds in medicaments, in particular as lipoxygenase inhibitors.
GR960402365T 1991-02-22 1996-09-12 2-Substituted quinolines, process for their preparation as well as their use in medicaments GR3021014T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105551A DE4105551A1 (en) 1991-02-22 1991-02-22 2-SUBSTITUTED CHINOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Publications (1)

Publication Number Publication Date
GR3021014T3 true GR3021014T3 (en) 1996-12-31

Family

ID=6425643

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402365T GR3021014T3 (en) 1991-02-22 1996-09-12 2-Substituted quinolines, process for their preparation as well as their use in medicaments

Country Status (20)

Country Link
EP (1) EP0499926B1 (en)
JP (1) JPH0592957A (en)
KR (1) KR920016424A (en)
AT (1) ATE142623T1 (en)
AU (1) AU641585B2 (en)
CZ (1) CZ282723B6 (en)
DE (2) DE4105551A1 (en)
DK (1) DK0499926T3 (en)
ES (1) ES2091958T3 (en)
FI (1) FI920732A (en)
GR (1) GR3021014T3 (en)
HU (1) HUT67037A (en)
IE (1) IE75728B1 (en)
IL (1) IL101009A (en)
MY (1) MY108459A (en)
NZ (1) NZ241654A (en)
PL (2) PL170726B1 (en)
RU (1) RU2077532C1 (en)
TW (1) TW200463B (en)
ZA (1) ZA921268B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4226649A1 (en) * 1992-08-12 1994-02-17 Bayer Ag New isobutyl-substituted methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid aminols
DE4112533A1 (en) * 1991-04-17 1992-10-22 Bayer Ag METHOD FOR THE PRODUCTION OF ENANTIOMER-PURE SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
TW232013B (en) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
DE4219765A1 (en) * 1992-06-17 1993-12-23 Bayer Ag Substituted (benzothiazolyl and quinoxalyl-methoxy) phenylacetic acid derivatives
DE4301900A1 (en) * 1993-01-25 1994-07-28 Bayer Ag 2-oxoquinoline-1-yl-methylphenylessigsäurederivate
ES2061406B1 (en) * 1993-05-07 1995-06-01 Uriach & Cia Sa J NEW DERIVATIVES OF 2- (QUINOLINE) WITH PHARMACOLOGICAL ACTIVITY.
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
DE69422450T2 (en) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Quinolines or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
DE4443892A1 (en) * 1994-12-09 1996-06-13 Bayer Ag 4- (Quinolin-2-yl-methoxy) phenyl acetic acid derivatives
DE4443891A1 (en) 1994-12-09 1996-06-13 Bayer Ag Heterocyclically substituted oxy-phenyl- (phenyl) glycinolamides
US6867320B2 (en) 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
BRPI0417543A (en) 2003-12-12 2007-03-27 Wyeth Corp quinolines useful in treating cardiovascular disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (en) * 1988-04-29 1989-11-09 Bayer Ag (ALPHA) -SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS AND SITES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICAMENTS
DE3900261A1 (en) * 1988-05-31 1989-12-07 Bayer Ag SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL-ACETIC ACID DERIVATIVES
DE3908298A1 (en) * 1989-03-14 1990-09-20 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-N, N'-SULFONYL HARVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE3916663A1 (en) * 1989-05-23 1990-11-29 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-ACYL-SULPHONAMIDES AND CYANAMIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE3927930A1 (en) * 1989-08-24 1991-02-28 Bayer Ag CYCLIC SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-VINEGAR-ACID DERIVATIVES
DE3927931A1 (en) * 1989-08-24 1991-02-28 Bayer Ag DISUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC DERIVATIVES

Also Published As

Publication number Publication date
EP0499926B1 (en) 1996-09-11
IL101009A (en) 1996-08-04
NZ241654A (en) 1994-11-25
TW200463B (en) 1993-02-21
FI920732A (en) 1992-08-23
RU2077532C1 (en) 1997-04-20
KR920016424A (en) 1992-09-24
AU1054292A (en) 1992-08-27
CZ282723B6 (en) 1997-09-17
HU9200582D0 (en) 1992-05-28
AU641585B2 (en) 1993-09-23
FI920732A0 (en) 1992-02-20
PL171026B1 (en) 1997-02-28
PL170726B1 (en) 1997-01-31
DE59207074D1 (en) 1996-10-17
MY108459A (en) 1996-09-30
IL101009A0 (en) 1992-11-15
ATE142623T1 (en) 1996-09-15
JPH0592957A (en) 1993-04-16
HUT67037A (en) 1995-01-30
DK0499926T3 (en) 1997-02-10
IE75728B1 (en) 1997-09-24
PL293534A1 (en) 1992-10-05
EP0499926A1 (en) 1992-08-26
IE920557A1 (en) 1992-08-26
DE4105551A1 (en) 1992-08-27
ES2091958T3 (en) 1996-11-16
CS51492A3 (en) 1992-12-16
ZA921268B (en) 1992-11-25

Similar Documents

Publication Publication Date Title
GR3021014T3 (en) 2-Substituted quinolines, process for their preparation as well as their use in medicaments
DK543787A (en) NAPHTHYRIDINE, QUINOLINE AND BENZOXAZINE CARBOXYLIC ACID COMPOUNDS WITH ANTIBACTERIAL ACTIVITY
EP0302525A3 (en) Quinolones as antibacterial agents
JPS5547658A (en) Substituted quinolinecarboxylic acid derivative
KR950011747B1 (en) Quinoline carboxylic acid perivatives
DK0612731T3 (en) New quinolone and naphthyridone carboxylic acid derivatives
AU589415B2 (en) Improved process for quinoline-3-carboxylic acid antibacterial agents
JPS57145862A (en) Quinolinecarboxylic acid derivative
JPS57109754A (en) N-benzoyl-omega-anilinoalkane carboxylic acid compound
EP0207497A3 (en) Quinolonecarboxylic acid derivative and process for its preparation
NO901171D0 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED AZETIDINYLPYRIDONCARBOXYLIC ACID DERIVATIVES.
IE800234L (en) 7-acylindolin-2-ones and 7-acylindolines.
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
IE42992L (en) PYRIMIDO [1,2-a] QUINOLINE DERIVATIVES
ES8706663A1 (en) Production of 2-thiochromenylidene acetoacetic ester
ES2051225A1 (en) Procedure for preparation of 1-ethyl-6-fluoro-7-(pyrrol-1- yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
FI922482A (en) FOERFARANDE FOER FRAMSTAELLNING AV KINOLINFOERENING.
JPS55100365A (en) Quinoline derivative and its preparation
IE811069L (en) Esters of substituted benzoic acid
GB1453427A (en) 4-oxo-1,2,3,4-tetrahydropyrido-2,3-d-pyrimidines